We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Vienna, Austria

ESTRO 2023

Session

Breast
Poster (Digital)
Clinical
Is there an optimal DIBH maneuver in breast cancer radiation therapy? – A pilot study
Anna Karlsson, Sweden
PO-1244
Breast cancer radiotherapy's impact on shoulder morbidity: Towards the consideration of a new OAR?
Zeineb Naimi, Tunisia
PO-1245
CDK4/6-I AND SRT IN THE TREATMENT OF HORMONE RECEPTOR POSITIVE BREAST CANCER BRAIN METASTASES
Esmeralda Scipilliti, Italy
PO-1246
Safety of CDKI combined with radiotherapy in hormone receptor positive breast cancer
Sara Falivene, Italy
PO-1247
Stereotactic APBI for early-stage breast cancer: 3-year outcomes of a prospective registry
Jonathan Cantalino, USA
PO-1249
Biomedical parameters identification for radiotherapy-induced fatigue evaluation:proof of principle
Chiara Feoli, Italy
PO-1250
Partial breast re-irradiation with IMRT for local recurrence after whole breast radiotherapy
Mattia Zaffaroni, Italy
PO-1251
Single fraction ablative preoperative RT for early-stage BC, the CRYSTAL trial: preliminary results
Mattia Zaffaroni, Italy
PO-1253
Toxicity analysis of breast cancer patients treated with VMAT and 3D-CRT
Jan Seppälä, Finland
PO-1255
Reduced cardiovascular events incidence in breast cancer patients treated with radiotherapy
Eugenia Otero Pla, Spain
PO-1256
Axillary lymph nodes incidental dose with standard 3D-CRT: a retrospective evaluation
Marzia Borgia, Italy
PO-1257
Local recurrence following mastectomy for invasive breast cancer: a single institution experience
Amanda Swan, United Kingdom
PO-1259
Radiodermatitis after bolus use in breast cancer patients treated with moderate hypofractionation
Elvisa Kozma, Albania
PO-1261
Non-inferior local control of IMRT-SIB compared to 3D-CRT-seqB - 5-year results of a phase III trial
Tobias Forster, Germany
PO-1262
The role of radiation therapy in patients with repeat or induced oligometastatic breast cancer
Ivica Ratosa, Slovenia
PO-1263
Risk stratification for internal mammary lymph node irradiation based on dynamic MRI vessel imaging
Sophie Therese Klusen, Germany
PO-1264
Accelerated fractionation in breast cancer. Results in our institution
Angel Calvo Tudela, Spain
PO-1267
Five-day accelerated partial breast irradiation with 3D radiotherapy. Experience in our institution
Angel Calvo Tudela, Spain
PO-1268
Cardiological monitoring and safety of 5-fraction whole breast irradiation: SAFE-FORWARD study
Carlotta Becherini, Italy
PO-1269
Ultra-hypofractioned WBI in early stage breast cancer: a multicentric observational study
Isabella Palumbo, Italy
PO-1271
Anatomic predictor of contralateral breast exposure in breast cancer radiotherapy
Zeineb Naimi, Tunisia
PO-1273
Simultaneous integrated boost within the lymphatic drainage system in breast cancer
Antonia Peiler, Germany
PO-1274
Ultra-hypofractionated breast radiotherapy & simultaneous integrated boost for early breast cancer
Angel Montero, Spain
PO-1275
Quality of life analysis of adjuvant external beam APBI in prospective randomized trial.
Petr Burkon, Czech Republic
PO-1276
External beam APBI in early breast cancer - final results of prospective single institution study.
Petr Burkon, Czech Republic
PO-1277
Halfmoon radiotherapy: a real-world experience in a single institution
Mattia Zaffaroni, Italy
PO-1278
Optical coherence tomography computational model to quantify radiotherapy induced skin effects
Meritxell Molla, Spain
PO-1280
External validation of the MSKCC nomogram for Ductal Carcinoma in Situ and risk factors analysis
Gabriela Oses, Spain
PO-1281
Comprehensive analysis to predict lymphedema after salvage irradiation in locoregional breast cancer
Hyunju Shin, Korea Republic of
PO-1284
Breast cancer adjuvant hypofractionated RT upfront to chemotherapy : acute toxicity interim data
GRAZIA Lazzari , Italy
PO-1286
real world experience with extreme hypofractionated breast RT in a tertiary care center in India
LINCOLN PUJARI, India
PO-1287
Preliminary toxicity data on Trastuzumab emtansine and concomitant radiotherapy in adjuvant setting
Carola Maria Elisa Perotti, Italy
PO-1288
Is deep inspiration breath hold the standard of care in breast irradiation? A national survey
Eva Maria Ambroa Rey, Spain
PO-1289
Validating pErsoNalized 3D-printed Unique breaSt SHELLs for radiotherapy (VENUS SHELL)
Giovanna Dipasquale, Switzerland
PO-1290
Ablative Raditherapy as primary treatment in inoperable and elderly women with breast cancer.
Santiago Velázquez Miranda, Spain
PO-1291
Patterns and longitudinal changes in the practice of breast cancer radiotherapy in Korea: KROG 22-01
Hae Jin Park, Korea Republic of
PO-1292
Implementation of daily online adaptive radiotherapy for post-operative whole breast irradiation
Koen Nelissen, The Netherlands
PO-1293
MELT: A novel tool to select the most suitable patients for extreme hypofractionation
Luis Mateu Castell, Spain
PO-1295
Regional Nodal Irradiation in N+Breast cancer with complete pathologic response?- Clinical practice
Joana Pisco, Portugal
PO-1296
Safety & feasibility of SIB in extreme 1-week hypofractionated radiotherapy for early breast cancer
Luis Mateu Castell, Spain
PO-1297
Clinical predictors of dosimetric precedence for (DIBH) radiation therapy for breast cancer
Sania Abdelqader, Jordan
PO-1298
SBRT for treatment of primary breast cancer in patients not undergoing surgery: a pilot study
Alexander Stessin, USA
PO-1299
Tattoo-less Chest Wall Irradiation (VMAT) using Surface Imaging
Boris Mueller, USA
PO-1300
Decision Regret in Breast Cancer Patients after Adjuvant Radiotherapy
Muemtaz Koeksal, Germany
PO-1301